Welcome to CDC stacks | Wild primate populations in emerging infectious disease research: the missing link? - 15478 | Emerging...Welcome to CDC stacks | Wild primate populations in emerging infectious disease research: the missing link? - 15478 | Emerging...

Communicable Diseases Disease Reservoirs Humans Phylogeny Primate Diseases Primates Research Research Article Sentinel ... Exposure to nonhuman primates has led to the emergence of important diseases, including Ebola hemorrhagic fever, AIDS, and ... Since emerging infectious diseases also pose serious threats to endangered and threatened primate species, studies of these ... Wild primate populations, an unexplored source of information regarding emerging infectious disease, may hold valuable clues to ...
more infohttps://stacks.cdc.gov/view/cdc/15478

Social structure and Escherichia coli sharing in a group-living wild primate, Verreauxs sifaka | BMC Ecology | Full TextSocial structure and Escherichia coli sharing in a group-living wild primate, Verreaux's sifaka | BMC Ecology | Full Text

We investigated the role of host social structure in the transmission of Escherichia coli in a wild population of primates, ... Epidemiological models often use information on host social contacts to predict the potential impact of infectious diseases on ... Nunn CL, Altizer S. Infectious diseases in primates: behaviour, ecology and evolution. Oxford: Oxford University Press; 2006. ... Griffin R, Nunn C. Community structure and the spread of infectious disease in primate social networks. Evol Ecol. 2012;26:779- ...
more infohttps://bmcecol.biomedcentral.com/articles/10.1186/s12898-016-0059-y

Collagen-induced arthritis in common marmosets: a new nonhuman primate model for chronic arthritis | Arthritis Research &...Collagen-induced arthritis in common marmosets: a new nonhuman primate model for chronic arthritis | Arthritis Research &...

Fifty percent of the animals developed semi-acute CIA while the other 50% displayed a more chronic disease. Both cellular (CD3/ ... This new model in marmosets more closely resembles chronic RA with respect to the chronic disease course and pathomorphological ... CD4 and CD3/CD8) and humoral responses (IgM and IgG) against CII were involved in the development of the disease. Besides mild ... in a small-sized nonhuman primate species (300 to 400 g at adult age); that is, the common marmoset (Callithrix jacchus). ...
more infohttps://arthritis-research.biomedcentral.com/articles/10.1186/ar3172

Increased Epidermal Growth Factor-Like Ligands Are Associated With Elevated Vascular Nicotinamide Adenine Dinucleotide...Increased Epidermal Growth Factor-Like Ligands Are Associated With Elevated Vascular Nicotinamide Adenine Dinucleotide...

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The ... like ligands and vascular nicotinamide adenine dinucleotide phosphate oxidase expression and activity in a primate model of ... Factor-Like Ligands Are Associated With Elevated Vascular Nicotinamide Adenine Dinucleotide Phosphate Oxidase in a Primate ... Factor-Like Ligands Are Associated With Elevated Vascular Nicotinamide Adenine Dinucleotide Phosphate Oxidase in a Primate ...
more infohttp://atvb.ahajournals.org/content/early/2012/08/09/ATVBAHA.112.256107

Update on Alamogordo Transfer  | Project R&R News | NewsUpdate on Alamogordo Transfer | Project R&R News | News

On July 1, 2010 at least 14 chimpanzees were moved from the Alamogordo Primate Facility (APF) to the Southwest National Primate ... and autoimmune diseases. Yet as NEAVS/Project R&R has shown through the research of our Science Director, Dr. Jarrod Bailey, ... Weve learned that the federal government plans to move more than 200 chimpanzees now living at the Alamogordo Primate Facility ... The U.S. National Institutes of Healths (NIH) plan to transfer an estimated 186 chimpanzees from the Alamogordo Primate ...
more infohttp://www.releasechimps.org/resources/article/update-on-alamogordo-transfer

Recent Articles | Primates And Disease/Medicine | The Scientist Magazine®| Page 4Recent Articles | Primates And Disease/Medicine | The Scientist Magazine®| Page 4

Most didnt believe French doctor Charles Louis Alphonse Laveran when he said hed spotted the causative agent of the disease- ... tags: primates x disease/medicine x The Scientist. » primates and disease/medicine ...
more infohttps://www.the-scientist.com/?articles.list/tagNo/2786,6/tags/primates,disease-medicine/pageNo/4/

Community structure and the spread of infectious disease in primate social networks | SpringerLinkCommunity structure and the spread of infectious disease in primate social networks | SpringerLink

Social networks Primates Infectious disease Parasite richness Sociality Comparative study Agent-based model ... Nunn CL (2002a) A comparative study of leukocyte counts and disease risk in primates. Evol 56:177-190Google Scholar ... Nunn CL (2002b) Spleen size, disease risk and sexual selection: a comparative study in primates. Evol Ecol Res 4:91-107Google ... Kasper C, Voelkl B (2009) A social network analysis of primate groups. Primates 50(4):343-356PubMedCrossRefGoogle Scholar ...
more infohttps://link.springer.com/article/10.1007/s10682-011-9526-2

Recent Articles | Primates, Ecology And Disease/Medicine | The Scientist Magazine®Recent Articles | Primates, Ecology And Disease/Medicine | The Scientist Magazine®

A combination gene-and-cell therapy has given a boy with a grievous skin disease a new lease on life, and has resolved a ... Boosting levels of a the immunosuppressive protein PD-L1 in blood stem cells halts diabetes in a mouse model of the disease. ... Infectious protein aggregates from the skin of human patients can cause disease in mice. ... Optogenetic and chemogenetic tools illuminate brain and behavior connections in nonhuman primates. ...
more infohttps://www.the-scientist.com/?articles.list/categoryNo/2625/category/The-Scientist/tagNo/2786,7,6/tags/primates,ecology,disease-medicine/

JCI -
A nonhuman primate model of inherited retinal diseaseJCI - A nonhuman primate model of inherited retinal disease

By contrast, the cone-rich macula of a nonhuman primate (NHP) closely mirrors that of the human retina. Consequently, well- ... We have identified 4 related NHPs at the California National Primate Research Center with visual impairment and findings from ... defined NHP models of heritable retinal diseases, particularly cone disorders that are predictive of human conditions, are ...
more infohttps://jci.org/articles/view/123980/pdf

New research detects Alzheimers disease markers in nonhuman primates | NSF - National Science FoundationNew research detects Alzheimer's disease markers in nonhuman primates | NSF - National Science Foundation

New research detects Alzheimers disease markers in nonhuman primates. Research investigating the evolution of the human brain ... As a part of their research to understand the evolution of the human brain and how it differs from those of other primates, ... "This research underscores the value of basic, comparative research in advancing our understanding of disease etiology and ... the profound memory impairment found in Alzheimers patients has not yet been demonstrated in nonhuman primates. Along with ...
more infohttps://nsf.gov/discoveries/disc_summ.jsp?org=NSF&cntn_id=242850&preview=false

JCI -
Usage information: A nonhuman primate model of inherited retinal diseaseJCI - Usage information: A nonhuman primate model of inherited retinal disease

By contrast, the cone-rich macula of a nonhuman primate (NHP) closely mirrors that of the human retina. Consequently, well- ... We have identified 4 related NHPs at the California National Primate Research Center with visual impairment and findings from ... defined NHP models of heritable retinal diseases, particularly cone disorders that are predictive of human conditions, are ...
more infohttps://jci.org/articles/view/123980/usage

Occurrence of stroke in a nonhuman primate model of cerebrovascular disease. | StrokeOccurrence of stroke in a nonhuman primate model of cerebrovascular disease. | Stroke

Occurrence of stroke in a nonhuman primate model of cerebrovascular disease.. S Prusty, T Kemper, M B Moss, W Hollander ... In our primate model hypertension is induced by surgical coarctation of the aorta. These monkeys, when fed an atherogenic diet ... Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The ...
more infohttp://stroke.ahajournals.org/content/19/1/84

Neural Stem Cell Transplants in a Primate Model of Parkinsons Disease - Fight Aging!Neural Stem Cell Transplants in a Primate Model of Parkinson's Disease - Fight Aging!

Neural Stem Cell Transplants in a Primate Model of Parkinsons Disease. Permalink Read 1 Comment Add a Comment Posted by Reason ... Researchers testing the potential of cell therapy for treating Parkinsons disease (PD) has found that grafting human ... Here is an example of ongoing work on stem cell transplants for the treatment of Parkinsons disease, in which the proximate ... parthenogenetic stem cell-derived neural stem cells (hpNSCs) into non-human primates modeled with PD promoted behavioral ...
more infohttps://www.fightaging.org/archives/2016/06/neural-stem-cell-transplants-in-a-primate-model-of-parkinsons-disease/

Modeling human arthritic diseases in nonhuman primates | Arthritis Research & Therapy | Full TextModeling human arthritic diseases in nonhuman primates | Arthritis Research & Therapy | Full Text

... and immunological similarity of nonhuman primates to humans may help to bridge the wide gap between inbred rodent strain models ... which has emerged as a reproducible model of human RA in nonhuman primates. ... Nonhuman primates spontaneously develop several of the arthritic diseases that affect the human population [9, 13]. However, ... t Hart BA, Losen M, Brok HPM, de Baets MH: Chronic diseases. The Laboratory Primate. Edited by: Wolfe-Coote SP. Amsterdam: ...
more infohttps://arthritis-research.biomedcentral.com/articles/10.1186/ar1773

BrainStorm Cell Therapeutics Initiates Stem Cell Safety Study in Primates for Parkinsons DiseaseBrainStorm Cell Therapeutics Initiates Stem Cell Safety Study in Primates for Parkinson's Disease

Nonhuman Primates Have a Starring Role in the Stem Cell Story News Some disorders are very primate-specific and there is a real ... BrainStorm Cell Therapeutics Initiates Stem Cell Safety Study in Primates for Parkinsons Disease News Feb 15, 2007 ... NIH Targets Genetic Cure for Sickle Cell Disease News The National Institutes of Health announced the launch of a new ... Nonhuman Primates Have a Starring Role in the Stem Cell Story News Sep 17, 2018 Read more ...
more infohttps://www.technologynetworks.com/cell-science/news/brainstorm-cell-therapeutics-initiates-stem-cell-safety-study-in-primates-for-parkinsons-disease-189176

Prevalence of age-related eye diseases in aging primates | IOVS | ARVO JournalsPrevalence of age-related eye diseases in aging primates | IOVS | ARVO Journals

Primate is an ideal disease model for investigation of pathogenesis and therapeutic approaches of eye diseases. Primate with ... Conclusions: 15 out of 92 primates (16.3%) were founded with eye diseases, which prevalence was similar to human eye diseases. ... aim to established the natural primate models for age related eye diseases. Moreover, a primate research center is funded for ... were observed in primates with the similar symptom as human being. More aging primate population is screening and more primates ...
more infohttps://iovs.arvojournals.org/article.aspx?articleid=2270800

Pallidal stimulation: effect of pattern and rate on bradykinesia in the non-human primate model of Parkinsons disease.Pallidal stimulation: effect of pattern and rate on bradykinesia in the non-human primate model of Parkinson's disease.

Deep brain stimulation (DBS) involves the delivery of continuous, fixed-frequency electrical pulses to specific brain regions; however the reliance of therapeutic benefit on the fixed-frequency nature of the stimulation pattern is currently unknown.
more infohttp://www.biomedsearch.com/nih/Pallidal-stimulation-Effect-pattern-rate/21767534.html

Table 3 - Susceptibilities of Nonhuman Primates to Chronic Wasting Disease - Volume 15, Number 9-September 2009 - Emerging...Table 3 - Susceptibilities of Nonhuman Primates to Chronic Wasting Disease - Volume 15, Number 9-September 2009 - Emerging...

We used 2 nonhuman primate species, cynomolgus macaques and squirrel monkeys, as human models for CWD susceptibility. CWD was ... In contrast, cynomolgus macaques have not shown evidence of clinical disease as of 70 months postinfection. Thus, these 2 ... diagnostic of prion disease. After oral exposure, 2 squirrel monkeys had PrPres in brain, spleen, and lymph nodes at 69 months ... or prion disease, that affects deer, elk, and moose. Human susceptibility to CWD remains unproven despite likely exposure to ...
more infohttps://wwwnc.cdc.gov/eid/article/15/9/09-0253-t3

Calorie restriction in non-human primates may prevent and reduce Alzheimers disease neuropathologyCalorie restriction in non-human primates may prevent and reduce Alzheimer's disease neuropathology

Calorie restriction in non-human primates may prevent and reduce Alzheimers disease neuropathology. 19.09.2006 ... "The findings offer a glimmer of hope that there may someday be a way to prevent and stop this devastating disease in its tracks ... Collectively, the study suggests that the investigation of calorie restriction in non-human primates may be a valuable approach ... which has been accepted for publication and will be published in the November 2006 issue of the Journal of Alzheimers Disease ...
more infohttps://www.innovations-report.com/hrml/reports/studies/report-70686.html

JCI -
siRNA rescues nonhuman primates from advanced Marburg and Ravn virus diseaseJCI - siRNA rescues nonhuman primates from advanced Marburg and Ravn virus disease

... primates at advanced stages of MARV or RAVV disease to mimic cases in which patients begin treatment for fulminant disease. ... While all untreated animals succumbed to disease, NP siRNA-LNP treatment conferred 100% survival of RAVV-infected macaques, ...
more infohttps://www.jci.org/articles/view/96185/sd/1

Figure 1 - Chronic Wasting Disease Agents in Nonhuman Primates - Volume 20, Number 5-May 2014 - Emerging Infectious Disease...Figure 1 - Chronic Wasting Disease Agents in Nonhuman Primates - Volume 20, Number 5-May 2014 - Emerging Infectious Disease...

To evaluate primate susceptibility, we tested monkeys from 2 genera. We found that 100% of intracerebrally inoculated and 92% ... Chronic wasting disease is a prion disease of cervids. Assessment of its zoonotic potential is critical. ... Chronic Wasting Disease Agents in Nonhuman Primates Brent Race. , Kimberly D. Meade-White, Katie Phillips, James Striebel, ... Centers for Disease Control and Prevention, * National Center for Emerging and Zoonotic Infectious Diseases (NCEZID). Office of ...
more infohttps://wwwnc.cdc.gov/eid/article/20/5/13-0778-f1

Immunization of Primates with a Newcastle Disease Virus-Vectored Vaccine via the Respiratory Tract Induces a High Titer of...Immunization of Primates with a Newcastle Disease Virus-Vectored Vaccine via the Respiratory Tract Induces a High Titer of...

Immunization of Primates with a Newcastle Disease Virus-Vectored Vaccine via the Respiratory Tract Induces a High Titer of ... Immunization of Primates with a Newcastle Disease Virus-Vectored Vaccine via the Respiratory Tract Induces a High Titer of ... Immunization of Primates with a Newcastle Disease Virus-Vectored Vaccine via the Respiratory Tract Induces a High Titer of ... Immunization of Primates with a Newcastle Disease Virus-Vectored Vaccine via the Respiratory Tract Induces a High Titer of ...
more infohttps://jvi.asm.org/content/81/21/11560?ijkey=05a828b750262aa3e76bf733231c758eea6dbea8&keytype2=tf_ipsecsha

Antiangiogenic activity of aganirsen in nonhuman primate and rodent models of retinal neovascular disease after topical...Antiangiogenic activity of aganirsen in nonhuman primate and rodent models of retinal neovascular disease after topical...

Antiangiogenic activity of aganirsen in nonhuman primate and rodent models of retinal neovascular disease after topical ... Eyedrops of aganirsen were applied daily in nonhuman primates after laser-induced choroidal neovascularization (CNV; model of ... Together, these findings support the clinical testing of aganirsen for human retinal neovascular diseases. ...
more infohttps://www.ncbi.nlm.nih.gov/pubmed?term=Cloutier%20F%2C%20Lawrence%20M%2C%20Goody%20R%2C%20Lamoureux%20S%2C%20Al

Parkinsons disease and primate research: past, present, and future. - Nuffield Department of Surgical SciencesParkinson's disease and primate research: past, present, and future. - Nuffield Department of Surgical Sciences

Research on primates has played--and continues to play--a crucial part in deepening our understanding of Parkinsons disease, ... This review discusses its role in the progress made towards our understanding of Parkinsons disease and its treatment. ... Established medical treatments like dopamine agonists continue to need primate models to assess their efficacy, safety, and ... The recently developed treatment of deep brain stimulation of the subthalamic nucleus required validation in primates before ...
more infohttps://www.nds.ox.ac.uk/publications/148136

Hair trace elementary profiles in aging rodents and primates: links to altered cell homeodynamics and disease | SpringerLinkHair trace elementary profiles in aging rodents and primates: links to altered cell homeodynamics and disease | SpringerLink

... cardiovascular and renal disease, and cancer. These conditions are believed to be linked to a... ... Hair trace elementary profiles in aging rodents and primates: links to altered cell homeodynamics and disease. ... 2.German Primate Center, Leibniz-Institute for Primate ResearchGöttingenGermany. *3.Department of NeurologyUniversity of ... Schroeder HJ (1967) Cadmium, chromium and cardiovascular disease. Circulation 35(3):570-582. doi: 10.1161/01.CIR.35.3.570 ...
more infohttps://link.springer.com/article/10.1007/s10522-013-9464-1